Please assess the completion status of the following clinical trial:

Trial Title: Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* More than 18 years old.~* Epidermoïde carcinoma or adenocarcinoma of the cervix, hystologic proved~* Patientes in a late stage or with progresive desease.~* One mesurable lesion in irradiated zone.~* Patient who have already treated radio-chimiothérapy with platine should have a 6 month free interval.~* Index status of ECOG ( Eastern Cooperative Oncology Group )less than 2.~* Good biologicals and hematologicals fonctions:~* Neutrophiles noless than 1,5.109/L.~* Platelets nolss than 100.109/L.~* Total bilirubin no more than 1,5 time the normal superior range.~* Transaminases no mote than 3 x Time NSR~* Creatinine clairance Cockroft) more than 50 mL/min .~* Inform consent signed.~Exclusion Criteria:~* Previous cytotoxic traitement exept radio-chaemiotherapy of the pelvis cerebrals metastasis.~* Other cancer in the last 5 years exept treated BCC.~* Dermatologic desease.~* Crohn desease or Hemorragic rectal-Colitis.~* Neuropathy.~* Psychologic disorder.~* Social troubles.~* Pregnant women.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).